Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 3
2014 6
2015 1
2016 3
2017 3
2020 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

15 results
Results by year
Filters applied: . Clear all
Page 1
European Respiratory Society guidelines for the diagnosis of primary ciliary dyskinesia.
Lucas JS, Barbato A, Collins SA, Goutaki M, Behan L, Caudri D, Dell S, Eber E, Escudier E, Hirst RA, Hogg C, Jorissen M, Latzin P, Legendre M, Leigh MW, Midulla F, Nielsen KG, Omran H, Papon JF, Pohunek P, Redfern B, Rigau D, Rindlisbacher B, Santamaria F, Shoemark A, Snijders D, Tonia T, Titieni A, Walker WT, Werner C, Bush A, Kuehni CE. Lucas JS, et al. Among authors: collins sa. Eur Respir J. 2017 Jan 4;49(1):1601090. doi: 10.1183/13993003.01090-2016. Print 2017 Jan. Eur Respir J. 2017. PMID: 27836958 Free PMC article.
Efficacy and safety of azithromycin maintenance therapy in primary ciliary dyskinesia (BESTCILIA): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial.
Kobbernagel HE, Buchvald FF, Haarman EG, Casaulta C, Collins SA, Hogg C, Kuehni CE, Lucas JS, Moser CE, Quittner AL, Raidt J, Rosthøj S, Sørensen AL, Thomsen K, Werner C, Omran H, Nielsen KG. Kobbernagel HE, et al. Among authors: collins sa. Lancet Respir Med. 2020 May;8(5):493-505. doi: 10.1016/S2213-2600(20)30058-8. Lancet Respir Med. 2020. PMID: 32380069 Clinical Trial.
Accuracy of diagnostic testing in primary ciliary dyskinesia.
Jackson CL, Behan L, Collins SA, Goggin PM, Adam EC, Coles JL, Evans HJ, Harris A, Lackie P, Packham S, Page A, Thompson J, Walker WT, Kuehni C, Lucas JS. Jackson CL, et al. Among authors: collins sa. Eur Respir J. 2016 Mar;47(3):837-48. doi: 10.1183/13993003.00749-2015. Epub 2015 Dec 2. Eur Respir J. 2016. PMID: 26647444 Free PMC article.
Study protocol, rationale and recruitment in a European multi-centre randomized controlled trial to determine the efficacy and safety of azithromycin maintenance therapy for 6 months in primary ciliary dyskinesia.
Kobbernagel HE, Buchvald FF, Haarman EG, Casaulta C, Collins SA, Hogg C, Kuehni CE, Lucas JS, Omran H, Quittner AL, Werner C, Nielsen KG. Kobbernagel HE, et al. Among authors: collins sa. BMC Pulm Med. 2016 Jul 22;16(1):104. doi: 10.1186/s12890-016-0261-x. BMC Pulm Med. 2016. PMID: 27450411 Free PMC article. Clinical Trial.
Cephalosporin-3'-Diazeniumdiolate NO Donor Prodrug PYRRO-C3D Enhances Azithromycin Susceptibility of Nontypeable Haemophilus influenzae Biofilms.
Collins SA, Kelso MJ, Rineh A, Yepuri NR, Coles J, Jackson CL, Halladay GD, Walker WT, Webb JS, Hall-Stoodley L, Connett GJ, Feelisch M, Faust SN, Lucas JS, Allan RN. Collins SA, et al. Antimicrob Agents Chemother. 2017 Jan 24;61(2):e02086-16. doi: 10.1128/AAC.02086-16. Print 2017 Feb. Antimicrob Agents Chemother. 2017. PMID: 27919896 Free PMC article.
Primary ciliary dyskinesia ciliated airway cells show increased susceptibility to Haemophilus influenzae biofilm formation.
Walker WT, Jackson CL, Allan RN, Collins SA, Kelso MJ, Rineh A, Yepuri NR, Nicholas B, Lau L, Johnston D, Lackie P, Faust SN, Lucas JSA, Hall-Stoodley L. Walker WT, et al. Among authors: collins sa. Eur Respir J. 2017 Sep 10;50(3):1700612. doi: 10.1183/13993003.00612-2017. Print 2017 Sep. Eur Respir J. 2017. PMID: 28890436 Free article.
15 results